Activated protein C resistance as a basis for venous thrombosis

American Journal of Medicine

Volumn 101, Issue 5, 1996, Pages 534-540

  Hillarp, Andreas ^a   Zöller, Bengt ^a   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; PROTEIN C;

BLOOD; BLOOD CLOTTING; GENETICS; GENOTYPE; HEMOPHILIA A; HUMAN; MUTATION; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; THROMBOSIS;

ANTICOAGULANTS; BLOOD COAGULATION; FACTOR V; GENOTYPE; HEMOPHILIA A; HUMANS; MUTATION; PHENOTYPE; PROTEIN C; THROMBOSIS;

EID: 0030280363     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00198-2     Document Type: Article

References (12)

1. Dahlbäck B, Stenflo J. The protein C anticoagulant system. in The Molecular basis of Blood Diseases (G. Stamatoyannopoulos, A.W. Nienhuis, P.W. Majerus and H. Varmus, ed.) Philadelphia: W.B. Saunders, 1994:599-628.
2. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90:1004-1008.
3. Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA. 1994;81:1396-1400.
4. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
5. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.
6. Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N EJ M. 1995;332:912-917.
7. Ridker PM, Miletich JP, Stampfer MJ, et al. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation. 1995;92:2800-2802.
8. Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 1994;94:2521-2524.
9. Koeleman BPC, Reitsma PH, Allaart RC, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood. 1994;84:1031-1035.
10. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1995;85:3518-3523.
11. Bauer KA. Management of patients with hereditary defects predisposing to thrombosis including pregnant women. Thromb Haemost. 1995;74:94-100.
12. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-1134.